Ficha del valor · trimestre archivado
AKRO
Akero Therapeutics, Inc. · Healthcare · Biotechnology
15Tenedores rastreados
-1Δ titulares
29.65MAcciones mantenidas
$1.58BValor declarado
+0Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables):
amplitud de titulares -6.2% ·
flujo de acciones -4.2% ·
nuevas posiciones netas -6.7%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2025 | 18 | 0 | 30.14M | $1.43B | +1 | −1 |
| Q2 2025 | 15 | -1 | 29.65M | $1.58B | — | −1 |
| Q1 2025 | 13 | +1 | 19.73M | $798.59M | +1 | — |
| Q4 2024 | 12 | +3 | 18.33M | $510.05M | +3 | — |
| Q3 2024 | 8 | 0 | 15.01M | $430.62M | +1 | −1 |
| Q2 2024 | 8 | — | 11.90M | $279.29M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 5.78M | — | $308.39M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 4.53M | — | $241.70M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 4.53M | — | $241.70M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 4.53M | — | $241.70M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 4.53M | — | $241.70M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 4.53M | — | $241.70M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 4.51M | -6.4% | $240.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 4.51M | -6.4% | $240.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 3.41M | -42.6% | $181.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (pasivo) | 2.75M | +10.1% | $146.50M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | Point72 Asset Management ✦ | 2.71M | +433.3% | $144.66M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 32 | Geode Capital Management ✦ (pasivo) | 1.72M | -1.5% | $91.92M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Geode Capital Management ✦ (pasivo) | 1.72M | -1.5% | $91.92M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Marshall Wace ✦ | 1.42M | -11.8% | $75.68M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 35 | Marshall Wace ✦ | 1.42M | -11.8% | $75.68M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 36 | Marshall Wace ✦ | 1.42M | -11.8% | $75.68M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 1.17M | -38.7% | $62.41M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 1.17M | -38.7% | $62.41M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 931.93K | — | $49.73M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 931.93K | — | $49.73M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 931.93K | — | $49.73M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Millennium Management ✦ | 314.99K | +36.4% | $16.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Adage Capital Partners ✦ | 295.00K | +51.3% | $15.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 53.87K | +343.0% | $2.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 33.75K | +485.6% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 33.75K | +485.6% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 33.75K | +485.6% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 48 | Renaissance Technologies ✦ | 28.00K | -85.9% | $1.49M | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Two Sigma Investments | $2.51M | era 0.0% |
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API